- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.02. | EC approves CSL's Andembry to prevent hereditary angioedema attacks | ||
| 14.02. | Are we masters of our own health? | ||
| 13.02. | Pfizer granted FDA approval for Adcetris combination in large B-cell lymphoma | ||
| 13.02. | FDA approves SpringWorks Therapeutics' Gomekli to treat neurofibromatosis type 1 | ||
| 13.02. | Eli Lilly and OliX partner to advance early-stage metabolic disease candidate | ||
| 12.02. | Novartis to expand cardiovascular pipeline with $3.1bn Anthos acquisition | ||
| 12.02. | Boehringer's nerandomilast shows promise in phase 3 pulmonary fibrosis study | ||
| 12.02. | CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix | ||
| 11.02. | AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections | ||
| 11.02. | Eli Lilly shares two-year results for Omvoh in active Crohn's disease patients | ||
| 11.02. | Inizio appoints Jim Sage as president of Inizio Engage | ||
| 10.02. | Inizio appoints Remco op den Kelder as president of Inizio Advisory | ||
| 10.02. | Roche announces positive late-stage results for Gazyva/Gazyvaro in lupus nephritis | ||
| 10.02. | CHMP recommends Bavarian Nordic's chikungunya vaccine for individuals aged from 12 years | ||
| 07.02. | Novo Nordisk's haemophilia A therapy Mim8 shows promise in late-stage study | ||
| 07.02. | International Alzheimer's disease prevention trial in at-risk young adults begins | ||
| 07.02. | Inizio appoints Colin Stanley as chief commercial officer | ||
| 06.02. | MHRA approves Valneva's chikungunya vaccine Ixchiq for use in adults | ||
| 06.02. | BMS receives CHMP recommendation for Breyanzi in follicular lymphoma | ||
| 06.02. | LEO and DEBRA Research partner to advance epidermolysis bullosa treatments | ||
| 06.02. | Shaping the future of pharma with human-centric transformation techniques | ||
| 05.02. | Novartis' Kisqali granted MHRA approval to treat early breast cancer patients | ||
| 05.02. | FDA approves Supernus Pharmaceuticals' Onapgo to treat advanced Parkinson's disease | ||
| 05.02. | Merck's adult-specific pneumococcal vaccine Capvaxive recommended by CHMP | ||
| 05.02. | GenAI and healthcare - potential that goes beyond established technologies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
